Impaired forearm blood flow and vasodilator reserve in healthy postmenopausal women

American Heart Journal

Volumn 137, Issue 4 I, 1999, Pages 692-697

  Mercuro, G ^a   Longu, G ^a   Zoncu, S ^a   Cherchi, A ^a  

^a Istituto di Cardiologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; NORADRENALIN;

ADRENERGIC SYSTEM; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTROGEN SYNTHESIS; FEMALE; FOREARM BLOOD FLOW; FUNCTIONAL ASSESSMENT; HEART RATE; HUMAN; INCIDENCE; MEAN ARTERIAL PRESSURE; NORADRENALIN BLOOD LEVEL; PATIENT POSITIONING; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; VASCULAR RESISTANCE; VEIN OCCLUSION PLETHYSMOGRAPHY;

EID: 0032936329     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70225-5     Document Type: Article

References (33)

1. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 1976;85:447-52.
2. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987;316:1105-10.
3. Castelli WP. Cardiovascular disease in women. Am J Obstet Gynecol 1988;158:1553-60.
4. La Vecchia C. Sex hormones and cardiovascular risk. Hum Reprod 1992;7:162-7.
5. Parrish HM, Carr LA, Hall DG. Time interval from castration in premenopausal women to development of excessive coronary atherosclerosis. Am J Obstet Gynecol 1967;99:155-62.
6. Sarrel PM. Ovarian hormones and the circulation. Maturitas 1990;12:287-98.
7. Wren BG. The effect of oestrogen on the female cardiovascular system. Med J Aust 1992;156:204-8.
8. Mendelsohn ME, Karas RH. Estrogen and the blood vessel wall. Cur Opin Cardiol 1994;9:619-26.
9. Mercuro G, Balloi C, De Candia G, Panzuto MG, Zoncu S, Cagnacci A. Effects of transdermal estrogen administration on peripheral vascular responsiveness in menopausal women. Int J Angiol 1997;6:237-40.
10. Mercuro G, Zoncu S, Pilia I, Lao A, Melis GB, Cherchi A. Effects of acute administration of transdermal estrogen on postmenopausal women with systemic hypertension. Am J Cardiol 1997;80:652-5.
11. Wren BG. HRT and the cardiovascular system. Aust Fam Physician 1992;21:226-9.
12. Samsioe G. Hormone replacement therapy and cardiovascular disease. Int J Fertil Menopausal Stud 1993;38(Suppl 1):23-9.
13. Stampfer MJ, Colditz GA, Willett WC. Postmenopausal estrogen therapy and cardiovascular disease. N Engl J Med 1991;325:756-62.
14. Rossetti ZL, Mercuro G, Rivano AC. A study of the parameters affecting flow gradient analysis of catecholamines, Dopa and Dopac by ion pair liquid chromatography with electrochemical detection. Life Sci 1983;33:2387-97.
15. Giannessi P, Zucchelli GC, Simonini N, Piro MA, Masini S, Malvano R. Methodological validation of human chorionic somatomammotropin, estriol, estradiol and progesterone radioimmunoassay in pregnancy. J Nucl All Sci 1978;22:71-5.
16. Murdaugh C. Coronary artery disease in women. J Cardiovasc Nurs 1990;4:35-50.
17. National Center for Health Statistics. Vital Statistics of the United States. 1989. Vol II: Mortality. Part A. Washington, DC: Government Printing Office. DHHS Publication (PHS) 1993; p. 93.
18. Witteman JC, Grobbee DE, Kok FJ, Hofman A, Valkenburg HA. Increased risk of atherosclerosis in women after the menopause. BMJ 1989;298:642-4.
19. Lindheim SR, Legro RS, Bernstein L. Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogen. Am J Obstet Gynecol 1992;167:1831-6.
20. Saab PG, Matthews KA, Stoney CM, McDonald RH. Premenopausal and postmenopausal women differ in their cardiovascular and neuroendocrine responses to behavioral stressors. Psychophysiology 1989;26:270-80.
21. Egan B, Panis R, Hinderliter A, Schork N, Julius S. Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension. J Clin Invest 1987;80:812-7.
22. Collins P, Sheridan D. Improvement in angina pectoris with adrenoreceptor blockade. Br Heart J 1985;53:488-92.
23. Berkenboom GM, Abramowicz M, Vandermoten P, Degre SG. Role of alpha-adrenergic coronary tone in exercise-induced angina pectoris. Am J Cardiol 1986;57:195-8.
24. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE. Aging is associated with endothelium dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 1994;24:471-5.
25. Stowell LI, McIntosh CJ, Cooke R. Adrenoceptor and imipramine receptor binding during the menstrual cycle. Acta Psychiatr Scand 1988;78:366-8.
26. Colucci WS, Gimbrone MA, Mc Laughlin MK. Increased vascular catecholamine sensitivity and a-adrenergic receptor affinity in female and estrogen-treated male rats. Circ Res 1982;50:805-11.
27. Owens JF, Stoney CM, Matthews KA. Menopausal status influences ambulatory blood pressure levels and blood pressure changes during mental stress. Circulation 1993;88:2794-802.
28. Mercuro G, Longu G, Cherchi A. Vascular changes related to estrogen deficiency in healthy postmenopausal women [abstract]. Eur Heart J 1996;17:34A.
29. Bush TL, Barrett-Connor E, Cowan LD. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987;75:1102-9.
30. Lobo RA. Cardiovascular implications of estrogen replacement therapy. Obstet Gynecol 1990;75(Suppl):18S-25S.
31. Grodstein F, Stampfer MJ, Manson JE, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. New Engl J Med 1996;335:453-61.
32. Grodstein F, Stampfer MJ, Colditz GA, Willett WC, Manson JAE, Joffe M. Postmenopausal hormone therapy and mortality. N Engl J Med 1997;336:1769-75.
33. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991;325:1196-204.